Trial
NCT01279187
The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan
Collaborators
Eli Lilly and Company
Condition
Implant
Intervention
Teriparatide
Why stopped
Study was terminated due to patient complications unrelated to study drugs
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-07